Tumor cells evade normal cell cycle and cell death regulatory processes, facilitated by inactivation of various tumor suppressors (e.g., p53 and PTEN), while the gain of oncogenic capabilities by others (e.g., MYC and RAS) increased proliferation rates compared to normal cells. This evidence concerns the gene MYC and neoplasm.